Working Group ”Therapy, Health Economics, and Quality of Life" Simone Accordini ECRHS Barcelona, 7...

5
Working Group ”Therapy, Health Economics, and Quality of Life" Simone Accordini ECRHS Barcelona, 7 September 2013

Transcript of Working Group ”Therapy, Health Economics, and Quality of Life" Simone Accordini ECRHS Barcelona, 7...

Page 1: Working Group ”Therapy, Health Economics, and Quality of Life" Simone Accordini ECRHS Barcelona, 7 September 2013.

Working Group

”Therapy, Health Economics, and Quality of Life"

Simone Accordini

ECRHS

Barcelona, 7 September 2013

Page 2: Working Group ”Therapy, Health Economics, and Quality of Life" Simone Accordini ECRHS Barcelona, 7 September 2013.

num

ber o

f pap

ers

number of papers: 16

overall Impact Factor (2012): 100

total number of citations: 395

0

1

2

3

4

5

2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014

Page 3: Working Group ”Therapy, Health Economics, and Quality of Life" Simone Accordini ECRHS Barcelona, 7 September 2013.

MAIN TOPICS: N° of papers First Authors

Changes in the use of anti-asthmatic treatment 1 Janson C

Asthma control and its determinants 1 Cazzoletti L

Asthma severity and its determinants 2 de Marco R

Cazzoletti L

Lung function decline and its determinants in asthma 3 de Marco R

Marcon A

Cerveri I

Asthma compliance and its determinants 1 Corsico A

Socio-economic burden of asthma and its determinants 2 Accordini S

Quality-of-life according to asthma severity and according to respiratory symptoms + methodological papers

4 Grassi M (2)

Siroux V

Voll-Aanerud M

Cluster-based identification of asthma phenotypes 2 Siroux V

Boudier A

Page 4: Working Group ”Therapy, Health Economics, and Quality of Life" Simone Accordini ECRHS Barcelona, 7 September 2013.

EARLIEST PAPERS TO WORK ON(WG meeting in Paris, 11-12 April 2013)

• Review of the main results obtained in the ECRHS II (Accordini S, Cazzoletti L)

• 20-yr changes in drug use in the general population + changes in ICS (Janson C, Marcon A)

• Description of treatment for rhinitis + long-term evolution (Leynaert B, Jarvis D)

• Cross-sectional treatment for COPD + determinants of use + long-term evolution

(Cerveri I, Corsico A)

• Long-term effect of ICS on LF decline in asthma and COPD (de Marco R, Siroux V)

• FeNO and ICS in asthmatics (Malinovschi A, Cazzoletti L)

Page 5: Working Group ”Therapy, Health Economics, and Quality of Life" Simone Accordini ECRHS Barcelona, 7 September 2013.

OTHER RESEARCH TOPICS:

• Evolution of asthma control

• Evolution of asthma severity

• Long-term outcomes of asthma medication

• Effect modifier of smoking and air pollution on asthma treatment benefits

• Methodological studies on the definition of asthma severity/control and on the definition of COPD

• Obesity and asthma/COPD

• Long-term outcomes of different asthma phenotypes (candidate approach/clustering methods)

• Health economics >> new collection of the economic data

• HRQL >> calculation of the scores

• Compliance